Skip to main content

Table 6 Comparisons of procedural parameters between SCE and non-SCE patients

From: Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study

Variables

SCE patients (n = 42)

Non-SCE patients (n = 58)

P value

PVI only (n, %)

15 (35.7%)

33 (56.9%)

0.036†

PVI plus (n, %)

27 (64.3%)

25 (43.1%)

Cardioversion (n, %)

17 (40.3%)

13 (22.4%)

0.052†

Procedure time (min, IQR)

210.0 (175.0–245.0)

190.0 (150.0–230.0)

0.122†

Radiofrequency time (min, mean ± SD)

40.6 ± 13.5

40.3 ± 11.9

0.902¶

Irrigation volume (ml, mean ± SD)

896.5 ± 268.1

866.9 ± 257.6

0.603¶

Loading dose of heparin (IU, IQR)

8000 (7375–8500)

8000 (7000–8500)

0.251*

Total dose of heparin (IU, IQR)

10,000 (8000–12,000)

8750 (8000–11,000)

0.253*

ACT before energy delivery (S, IQR)

292.0 (273.0–326.0)

299.5 (268.8–335.0)

0.572*

Mean ACT during procedure (S, IQR)

288.5 (266.8–303.0)

296.0 (279.8–311.3)

0.227*

Maximum ACT during procedure (S, IQR)

301.5 (288.0–330.3)

317.0 (298.0–336.3)

0.149*

Minimum ACT during procedure (S, IQR)

275.0 (245.3–285.3)

276.5 (254.5–291.8)

0.426*

Steam pop (n, %)

1 (2.4%)

3 (5.2%)

0.637‡

Pericardial effusion (n, %)

0

3 (5.2%)

0.262‡

  1. ACT activated clotting time, IQR interquartile range, PVI pulmonary vein isolation, SCE silent cerebral embolism
  2. *Mann–Whitney U test
  3. ¶Student’s t-test
  4. †Chi-square test
  5. ‡Fisher's exact test